Andreas Halvorsen - Viking Global Investors
Holding/activity history for Trevi Therapeutics, Inc. (TRVI)
← All TRVI superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 3,198,644 | 0.11 | $11.93 | $38,159,823 | SEC | ||
| 2025 Q4 | 3,198,644 | 0.11 | Reduce 37.63% | 0.05 | $9.28–14.39 · VW $11.87i | $40,047,023 | SEC |
| 2025 Q3 | 5,128,875 | 0.12 | Add 232.40% | 0.08 | $5.78–9.99 · VW $7.80i | $46,929,206 | SEC |
| 2025 Q2 | 1,543,000 | 0.02 | Reduce 52.20% | 0.03 | $4.85–7.48 · VW $6.30i | $8,440,210 | SEC |
| 2025 Q1 | 3,227,792 | 0.06 | Reduce 26.64% | 0.02 | $3.47–7.39 · VW $5.99i | $20,302,812 | SEC |
| 2024 Q4 | 4,400,000 | 0.06 | $4.12 | $18,128,000 | SEC | ||
| 2024 Q3 | 4,400,000 | 0.05 | $3.34 | $14,696,000 | SEC | ||
| 2024 Q2 | 4,400,000 | 0.05 | $2.98 | $13,112,000 | SEC | ||
| 2024 Q1 | 4,400,000 | 0.06 | $3.45 | $15,180,000 | SEC | ||
| 2023 Q4 | 4,400,000 | 0.02 | $1.34 | $5,896,000 | SEC | ||
| 2023 Q3 | 4,400,000 | 0.04 | $2.18 | $9,592,000 | SEC | ||
| 2023 Q2 | 4,400,000 | 0.04 | $2.39 | $10,516,000 | SEC | ||
| 2023 Q1 | 4,400,000 | 0.04 | $1.85 | $8,140,000 | SEC | ||
| 2022 Q4 | 4,400,000 | 0.04 | $1.93 | $8,492,000 | SEC | ||
| 2022 Q3 | 4,400,000 | 0.03 | Buy | 0.03 | $1.43–4.68 · VW $3.25i | $6,776,000 | SEC |
Price snapshot:
Current price$16.52
Avg. buy price$6.86
+/- since buy140.80%
52-week low$6.50
52-week high$20.15